Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Июль 12, 2024
Background
Delivery
systems
based
on
albumin
nanoparticles
(NPs)
have
recently
garnered
substantial
interest
in
anti-tumor
drug
development.
However,
systematic
bibliometric
analyses
this
field
remain
lacking.
This
study
aimed
to
analyze
the
current
research
status,
hotspots,
and
frontiers
application
of
NPs
oncology
from
a
perspective.
Methods
Using
Web
Science
Core
Collection
(WOSCC)
as
data
source,
retrieved
articles
were
analyzed
using
software,
such
VOSviewer
1.6.18
CiteSpace
6.1.6,
relevant
visualization
maps
plotted.
Results
From
1
January
2000,
15
April
2024,
2,262
institutions
67
countries/regions
published
1,624
related
oncology.
The
USA
was
leader
held
formidable
academic
reputation.
most
productive
institution
Chinese
Academy
Sciences.
author
Youn
YS,
whereas
Kratz
F
frequently
co-cited
author.
journal
International
Journal
Nanomedicine
,
Controlled
Release
journal.
Future
hotspots
included
“rapid
convenient
synthesis
methods
predominated
by
self-assembly,”
“surface
modification,”
“construction
multifunctional
for
theranostics,”
“research
natural
active
ingredients
mainly
phenolic
compounds,”
“combination
therapy,”
“clinical
applications.”
Conclusion
Based
our
analysis
summary,
we
obtained
an
overview
oncology,
identified
influential
countries,
institutions,
authors,
journals,
citations,
discussed
field.
Our
may
serve
important
reference
future
Nanomaterials,
Год журнала:
2023,
Номер
13(21), С. 2887 - 2887
Опубликована: Окт. 31, 2023
Timely
diagnosis
and
appropriate
antitumoral
treatments
remain
of
utmost
importance,
since
cancer
remains
a
leading
cause
death
worldwide.
Within
this
context,
nanotechnology
offers
specific
benefits
in
terms
therapy
by
reducing
its
adverse
effects
guiding
drugs
to
selectively
target
cells.
In
comprehensive
review,
we
have
summarized
the
most
relevant
novel
outcomes
range
2010-2023,
covering
design
application
nanosystems
for
therapy.
We
established
general
requirements
nanoparticles
be
used
drug
delivery
strategies
their
uptake
tumor
microenvironment
vasculature,
including
reticuloendothelial
system
surface
functionalization
with
protein
corona.
After
brief
review
classes
nanovectors,
covered
different
therapies.
First,
advances
encapsulation
(such
as
paclitaxel
fisetin)
into
nanoliposomes
nanoemulsions
are
described,
well
relevance
current
clinical
trials.
Then,
polymeric
presented,
namely
ones
comprising
poly
lactic-co-glycolic
acid,
polyethylene
glycol
(and
PEG
dilemma)
dendrimers.
The
quantum
dots
bioimaging
is
also
covered,
systems
zinc
sulfide
indium
phosphide.
Afterwards,
reviewed
gold
(spheres
anisotropic)
plasmon-induced
photothermal
iron
oxide
nanoparticles,
such
magnetite
maghemite,
has
been
analyzed
fields,
magnetic
resonance
imaging,
immunotherapy,
hyperthermia,
delivery.
Lastly,
recent
using
carbon
nanomaterials,
graphene
oxide,
nanotubes,
fullerenes,
dots.
Finally,
compared
passive
active
targeting
theranostics.
This
aims
(nano)mark
on
ongoing
journey
towards
realizing
remarkable
potential
realm
therapeutics.
Abstract
Gold
nanoparticles
(AuNPs)
are
promising
materials
for
many
bioapplications.
However,
upon
contacting
with
biological
media,
AuNPs
undergo
changes.
The
interaction
proteins
results
in
the
so‐called
protein
corona
(PC)
around
AuNPs,
leading
to
new
bioidentity
and
optical
properties.
Understanding
mechanisms
of
PC
formation
its
functions
can
help
us
utilise
benefits
avoid
drawbacks.
To
date,
most
previous
works
aimed
understand
governing
focused
on
spherical
nanoparticles,
although
non‐spherical
designed
a
wide
range
applications
biosensing.
In
this
work,
we
investigated
differences
anisotropic
(nanostars
particular)
from
joint
experimental
(extinction
spectroscopy,
zeta
potential
surface‐enhanced
Raman
scattering
[SERS])
computational
methods
(the
finite
element
method
molecular
dynamics
[MD]
simulations).
We
discovered
that
does
not
fully
cover
surface
leaving
SERS
hot‐spots
at
tips
high
curvature
edges
‘available’
analyte
binding
(no
signal
after
pre‐incubation
protein)
while
providing
protein‐induced
stabilization
(indicated
by
extinction
spectroscopy)
layer
particle's
core.
findings
confirmed
our
MD
simulations,
adsorption
energy
significantly
decreases
increased
radius
curvature,
so
(adsorption
energy:
2762.334
kJ/mol)
would
be
least
preferential
site
compared
core
11819.263
kJ/mol).
These
observations
will
development
nanostructures
improved
sensing
targeting
ability.
Nanomaterials,
Год журнала:
2024,
Номер
14(10), С. 823 - 823
Опубликована: Май 8, 2024
Understanding
both
the
physicochemical
and
biological
interactions
of
nanoparticles
is
mandatory
for
biomedical
application
nanomaterials.
By
binding
proteins,
acquire
new
surface
identities
in
fluids,
protein
corona.
Various
studies
have
revealed
dynamic
structure
nano–bio
The
proteins
not
only
imparts
to
fluids
but
also
significantly
influences
their
bioactivity,
stability,
targeting
specificity.
Interestingly,
recent
endeavors
been
undertaken
harness
potential
corona
instead
evading
its
presence.
Exploitation
this
‘protein–nanoparticle
alliance’
has
significant
change
field
nanomedicine.
Here,
we
present
a
thorough
examination
latest
research
on
corona,
encompassing
formation,
dynamics,
developments,
diverse
bioapplications.
Furthermore,
aim
explore
at
interface,
paving
way
innovative
strategies
advance
addressing
challenges
promises
controlling
review
provides
insights
into
evolving
landscape
highlights
emerging.
Biomimetics,
Год журнала:
2022,
Номер
7(3), С. 126 - 126
Опубликована: Сен. 6, 2022
Nanoparticles
(NPs)
are
usually
treated
as
multifunctional
agents
combining
several
therapeutical
applications,
like
imaging
and
targeting
delivery.
However,
clinical
translation
is
still
largely
hindered
by
factors,
the
rapidly
formed
protein
corona
on
surface
of
NPs
one
them.
The
formation
complicated
irreversible
in
biological
environment,
will
redefine
"biological
identity"
NPs,
which
alter
following
events
therapeutic
efficacy.
Current
understanding
limited
incomplete,
many
cases,
has
adverse
impacts
nanomedicine,
for
instance,
losing
ability,
activating
immune
response,
rapid
clearance.
Due
to
considerable
role
NPs'
fate,
harnessing
achieve
some
effects
through
various
methods
biomimetic
approaches
now
a
promising
way
meet
current
challenges
nanomedicine
such
poor
pharmacokinetic
properties,
off-target
effect,
immunogenicity.
This
review
first
introduce
summarize
investigation
process
technologies.
Second,
strategies
with
design
reviewed.
Finally,
we
discuss
future
outlooks
tune
nanomedicine.
Pharmaceutics,
Год журнала:
2023,
Номер
15(5), С. 1450 - 1450
Опубликована: Май 10, 2023
Gene
therapy
has
emerged
as
a
powerful
tool
to
treat
various
diseases,
such
cardiovascular
neurological
ocular
diseases
and
cancer
diseases.
In
2018,
the
FDA
approved
Patisiran
(the
siRNA
therapeutic)
for
treating
amyloidosis.
Compared
with
traditional
drugs,
gene
can
directly
correct
disease-related
genes
at
genetic
level,
which
guarantees
sustained
effect.
However,
nucleic
acids
are
unstable
in
circulation
have
short
half-lives.
They
cannot
pass
through
biological
membranes
due
their
high
molecular
weight
massive
negative
charges.
To
facilitate
delivery
of
acids,
it
is
crucial
develop
suitable
strategy.
The
rapid
development
systems
brought
light
field,
overcome
multiple
extracellular
intracellular
barriers
that
prevent
efficient
acids.
Moreover,
emergence
stimuli-responsive
made
possible
control
release
an
intelligent
manner
precisely
guide
therapeutic
target
site.
Considering
unique
properties
systems,
nanocarriers
been
developed.
For
example,
taking
advantage
physiological
variations
tumor
(pH,
redox
enzymes),
biostimuli-
or
endogenous
fabricated
processes
manner.
addition,
other
external
stimuli,
light,
magnetic
fields
ultrasound,
also
employed
construct
nanocarriers.
Nevertheless,
most
preclinical
stage,
some
critical
issues
remain
be
solved
advancing
clinical
translation
these
nanocarriers,
unsatisfactory
transfection
efficiency,
safety
issues,
complexity
manufacturing
off-target
effects.
purpose
this
review
elaborate
principles
emphasize
influential
advances
systems.
Current
challenges
corresponding
solutions
will
highlighted,
accelerate
advance
therapy.
Expert Opinion on Drug Delivery,
Год журнала:
2024,
Номер
21(4), С. 553 - 572
Опубликована: Апрель 2, 2024
Intranasal
administration
is
an
effective
drug
delivery
routes
in
modern
pharmaceutics.
However,
unlike
other
vivo
biological
barriers,
the
nasal
mucosal
barrier
characterized
by
high
turnover
and
selective
permeability,
hindering
diffusion
of
both
particulate
systems
molecules.
The
fate
administrated
nanomedicines
often
significantly
affected
nano-biointeractions.